Author:
Chidambaram Saravana Babu,Essa Mohamed,Qoronfleh M. Walid
Publisher
Springer Nature Singapore
Reference56 articles.
1. Adinortey MB, Ansah C, Galyuon I, Nyarko A (2013) In vivo models used for evaluation of potential antigastroduodenal ulcer agents. Ulcers 2013:e796405. https://doi.org/10.1155/2013/796405
2. Al-Saffar A, da Costa AN, Delaunois A, Leishman DJ, Marks L, Rosseels M-L, Valentin J-P (2015) Gastrointestinal safety pharmacology in drug discovery and development. In: Pugsley MK, Curtis MJ (eds) Principles of safety pharmacology, handbook of experimental pharmacology. Springer, Berlin Heidelberg, Berlin, Heidelberg, pp 291–321. https://doi.org/10.1007/978-3-662-46943-9_12
3. Andrade EL, Bento AF, Cavalli J, Oliveira SK, Schwanke RC, Siqueira JM, Freitas CS, Marcon R, Calixto JB (2016) Non-clinical studies in the process of new drug development—Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies. Braz J Med Biol Res 49:e5646. https://doi.org/10.1590/1414-431X20165646
4. Anonymous (2018) ICH S7A Safety pharmacology studies for human pharmaceuticals. European Medicines Agency. https://www.ema.europa.eu/en/ich-s7a-safety-pharmacology-studies-human-pharmaceuticals. Accessed 23 July 2021
5. Bari IN et al (2020) Effect of Plumeria rubra (Apocynaceae) leaf extracts, a repellent of rice-field rats (Rattus argentiventer), on its metabolism and daily activity. Rev Biol Trop 68(4):1357–1370